FDA Inspection
Naseem A. Jaffrani, M.D.Naseem A. Jaffrani, M.D. – FDA Inspection, Mar 13, 2025
Record Details
This FDA Inspection record concerns Naseem A. Jaffrani, M.D., with an inspection on March 13, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 96752f27-f4ce-4b23-a5a2-f6468691536e
Inspection Facts
- Inspection number
- 1263799
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
7- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.64(b)Safety Reports - Non-Serious Events
- 21 CFR 312.64(b)Safety Reports - Serious Events
- 21 CFR 312.66Changes in research
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.